Search research articles
Contact Us
Filters
Showing results (11-20 of 52) with videos related to
Page
of 6
Sort By:
Die Pharmazie
|
September 1, 1988
[Drug transport through artificial lipoid membranes. 22. Amplitude of ultrasonicated liposomes as a model system for investigations of drug transport]
S Schneider, S Grundner, R Neubert, et al.
Die Pharmazie
|
June 1, 1984
[Drug permeation through artificial lipid membranes. 17. The mechanism of ion pair transport]
R Neubert, W Fürst, W Böhm, et al.
Die Pharmazie
|
May 1, 1985
[Dissolution processes and surface alteration. 4. Determination of the "effective" surface]
R Neubert, W Fürst, H Frenzel, et al.
Die Pharmazie
|
February 1, 1987
[Preparation of a cytostatic-containing bone cement]
D Lösche, W Fürst, M Falk, et al.
Die Pharmazie
|
January 1, 1980
[Drug permeation through synthetic lipid membranes. Part 13: The effects of tensides on the permeation of ionized drugs (author's transl)]
W Fürst, R Neubert, B Förster, et al.
European Journal of Biochemistry
|
May 15, 1994
Hydrolysis of lactosylceramide by human galactosylceramidase and GM1-beta-galactosidase in a detergent-free system and its stimulation by sphingolipid activator proteins, sap-B and sap-C. Activator proteins stimulate lactosylceramide hydrolysis
A Zschoche, W Fürst, G Schwarzmann, et al.
The Journal of Biological Chemistry
|
January 25, 1991
The human GM2 activator protein. A substrate specific cofactor of beta-hexosaminidase A
E M Meier, G Schwarzmann, W Fürst, et al.
Die Pharmazie
|
September 1, 1993
[Improvement of the absorption of the active substance 2'-hydroxy-5'-methyllaurophenoxamine (FLM 5011) with prodrugs and preparations]
C Tscheuschner, R Neubert, W Fürst, et al.
Die Pharmazie
|
August 1, 1982
[Feasibility of the in vitro evaluation of bioavailability. 3: Method of operation of a newly-developed absorption model and results obtained with it]
W Fürst, R Neubert, B Stütz, et al.
Die Pharmazie
|
July 1, 1987
[Possibilities for the in vitro evaluation of bioavailability. 5. Compact peroral agents with basic drugs]
W Fürst, R Neubert, C Bendas, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 52) with videos related to
Sort By:
Page
of 6
Die Pharmazie
|
September 1, 1988
[Drug transport through artificial lipoid membranes. 22. Amplitude of ultrasonicated liposomes as a model system for investigations of drug transport]
S Schneider, S Grundner, R Neubert, et al.
Die Pharmazie
|
June 1, 1984
[Drug permeation through artificial lipid membranes. 17. The mechanism of ion pair transport]
R Neubert, W Fürst, W Böhm, et al.
Die Pharmazie
|
May 1, 1985
[Dissolution processes and surface alteration. 4. Determination of the "effective" surface]
R Neubert, W Fürst, H Frenzel, et al.
Die Pharmazie
|
February 1, 1987
[Preparation of a cytostatic-containing bone cement]
D Lösche, W Fürst, M Falk, et al.
Die Pharmazie
|
January 1, 1980
[Drug permeation through synthetic lipid membranes. Part 13: The effects of tensides on the permeation of ionized drugs (author's transl)]
W Fürst, R Neubert, B Förster, et al.
European Journal of Biochemistry
|
May 15, 1994
Hydrolysis of lactosylceramide by human galactosylceramidase and GM1-beta-galactosidase in a detergent-free system and its stimulation by sphingolipid activator proteins, sap-B and sap-C. Activator proteins stimulate lactosylceramide hydrolysis
A Zschoche, W Fürst, G Schwarzmann, et al.
The Journal of Biological Chemistry
|
January 25, 1991
The human GM2 activator protein. A substrate specific cofactor of beta-hexosaminidase A
E M Meier, G Schwarzmann, W Fürst, et al.
Die Pharmazie
|
September 1, 1993
[Improvement of the absorption of the active substance 2'-hydroxy-5'-methyllaurophenoxamine (FLM 5011) with prodrugs and preparations]
C Tscheuschner, R Neubert, W Fürst, et al.
Die Pharmazie
|
August 1, 1982
[Feasibility of the in vitro evaluation of bioavailability. 3: Method of operation of a newly-developed absorption model and results obtained with it]
W Fürst, R Neubert, B Stütz, et al.
Die Pharmazie
|
July 1, 1987
[Possibilities for the in vitro evaluation of bioavailability. 5. Compact peroral agents with basic drugs]
W Fürst, R Neubert, C Bendas, et al.
Page
of 6